We are live on ! Find out more
State of Wisconsin Investment Board

State of Wisconsin Investment Board Portfolio holdings

AUM $43.7B
1-Year Est. Return 27.76%
This Fund
S&P 500
This Quarter Est. Return
+8.71%
1 Year Est. Return
+27.76%
3 Year Est. Return
+95.56%
5 Year Est. Return
+123.77%
10 Year Est. Return
+486.44%
AUM
$48.3B
AUM Growth
+$1.43B
Cap. Flow
-$2B
Cap. Flow %
-4.15%
Top 10 Hldgs %
18.68%
Holding
2,220
New
201
Increased
548
Reduced
910
Closed
160

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$54.5M
2
META icon
Meta Platforms (Facebook)
META
+$49.7M
3
AZN icon
AstraZeneca
AZN
+$43.2M
4
BIIB icon
Biogen
BIIB
+$42.5M
5
ACN icon
Accenture
ACN
+$38.3M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$115M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$106M
3
JNK icon
State Street SPDR Bloomberg High Yield Bond ETF
JNK
+$92.5M
4
MSFT icon
Microsoft
MSFT
+$76.6M
5
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$73.2M

Sector Composition

Rank Sector Weight
1 Technology 22.49%
2 Financials 14.31%
3 Healthcare 13.25%
4 Consumer Discretionary 11.35%
5 Communication Services 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRPT icon
1576
Sarepta Therapeutics
SRPT
$1.95B
$708K ﹤0.01%
9,113
-55,158
-86% -$4.18M
LXRX icon
1577
Lexicon Pharmaceuticals
LXRX
$1.04B
$705K ﹤0.01%
153,700
+99,100
+182% +$477K
AKBA icon
1578
Akebia Therapeutics
AKBA
$241M
$704K ﹤0.01%
185,734
– –
PATH icon
1579
UiPath
PATH
$8.64B
$704K ﹤0.01%
+10,365
New +$760K
VVV icon
1580
Valvoline
VVV
$4.31B
$702K ﹤0.01%
21,628
-1,416
-6% -$44K
EXP icon
1581
Eagle Materials
EXP
$6.41B
$698K ﹤0.01%
4,911
-322
-6% -$46.3K
ICPT
1582
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$697K ﹤0.01%
34,900
– –
HR icon
1583
Healthcare Realty
HR
$6.58B
$694K ﹤0.01%
25,986
-1,583
-6% -$44.8K
VYX icon
1584
NCR Voyix
VYX
$1.17B
$694K ﹤0.01%
24,807
-1,741
-7% -$48.2K
ARQT icon
1585
Arcutis Biotherapeutics
ARQT
$3.25B
$690K ﹤0.01%
25,300
– –
CC icon
1586
Chemours
CC
$2.3B
$684K ﹤0.01%
19,656
-1,057
-5% -$35K
SANA icon
1587
Sana Biotechnology
SANA
$1.1B
$682K ﹤0.01%
+34,700
New +$786K
PEGA icon
1588
Pegasystems
PEGA
$5.51B
$678K ﹤0.01%
9,738
-262
-3% -$16.5K
HLF icon
1589
Herbalife
HLF
$1.28B
$676K ﹤0.01%
12,824
+1,421
+12% +$70.7K
ENNVU
1590
DELISTED
ECP Environmental Growth Opportunities Corp. Unit
ENNVU
$676K ﹤0.01%
66,895
+100
+0.1% +$1.01K
EXEL icon
1591
Exelixis
EXEL
$12.5B
$674K ﹤0.01%
36,966
-2,021
-5% -$47.1K
CLVS
1592
DELISTED
Clovis Oncology, Inc.
CLVS
$669K ﹤0.01%
115,282
– –
IONS icon
1593
Ionis Pharmaceuticals
IONS
$9.28B
$668K ﹤0.01%
16,749
-55,456
-77% -$2.17M
FL
1594
DELISTED
Foot Locker
FL
$667K ﹤0.01%
10,823
-2,399
-18% -$145K
RL icon
1595
Ralph Lauren
RL
$23.1B
$666K ﹤0.01%
5,654
-317
-5% -$39.7K
ACHC icon
1596
Acadia Healthcare
ACHC
$2.82B
$663K ﹤0.01%
10,561
-583
-5% -$36.6K
NATI
1597
DELISTED
National Instruments Corp
NATI
$662K ﹤0.01%
15,668
-676
-4% -$28.5K
BCAB icon
1598
BioAtla
BCAB
$5.73M
$661K ﹤0.01%
312
– –
VNT icon
1599
Vontier
VNT
$4.47B
$661K ﹤0.01%
20,276
+831
+4% +$27.4K
NGM
1600
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$661K ﹤0.01%
33,500
– –
62 63
64
65 66

Similar funds

Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
PEAK6
PEAK6 Chicago, Illinois $42.6B AUM 66.24% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

State of Wisconsin Investment Board's Q2 2021 Portfolio in Review

As of Q2 2021, State of Wisconsin Investment Board held 2,220 positions worth $48.3B, up 3.1% from $46.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

State of Wisconsin Investment Board withdrew a net $2B in Q2 2021, closing 160 positions and reducing 910 holdings. Its most notable exit was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $92.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

Against the trend, State of Wisconsin Investment Board opened a new position in AstraZeneca worth $47.2M.

  • State of Wisconsin Investment Board's largest Q2 2021 buy was AstraZeneca: 394,075 shares worth $47.2M.
  • State of Wisconsin Investment Board added most to Alphabet (Google) Class A in Q2 2021, an estimated $54.5M increase.
  • State of Wisconsin Investment Board's biggest Q2 2021 reduction was Johnson & Johnson, cutting an estimated $115M.
  • State of Wisconsin Investment Board fully exited State Street SPDR Bloomberg High Yield Bond ETF in Q2 2021, selling an estimated $92.5M.
  • State of Wisconsin Investment Board's ten largest holdings make up 19% of its $48.3B portfolio in Q2 2021.
  • State of Wisconsin Investment Board opened 201 new positions and closed 160 in Q2 2021.
  • State of Wisconsin Investment Board's portfolio value rose 3.1% quarter-over-quarter to $48.3B.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2021, filed 12 Aug 2021.